Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Scienture Holdings Inc (SCNX)

Scienture Holdings Inc (SCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA GlobeNewswire - Mon Dec 22, 2025

U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company...

SCNX : 0.5100 (+3.01%)
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium GlobeNewswire - Wed Dec 10, 2025

U.S. Losartan market totals $245M annually with 71M prescriptions  COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and...

SCNX : 0.5100 (+3.01%)
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 ACCESS Newswire - Mon Dec 8, 2025

RALEIGH, NC / ACCESS Newswire / December 8, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and...

MOB : 6.10 (+1.84%)
BOSC : 4.56 (-2.77%)
STRT : 76.14 (-1.31%)
ELWT : 5.07 (+6.96%)
FLUX : 1.2700 (-1.55%)
DGX.VN : 3.480 (-1.69%)
BCHT.TO : 4.98 (+365.42%)
GAME : 0.3850 (-3.75%)
WYY : 5.37 (-2.54%)
ACNT : 16.19 (-2.18%)
DCGO : 0.8778 (-0.28%)
VELO : 13.74 (-5.70%)
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 GlobeNewswire - Tue Dec 2, 2025

COMMACK, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced...

SCNX : 0.5100 (+3.01%)
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 ACCESS Newswire - Mon Dec 1, 2025

RALEIGH, NC / ACCESS Newswire / December 1, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and...

MOB : 6.10 (+1.84%)
BOSC : 4.56 (-2.77%)
STRT : 76.14 (-1.31%)
ELWT : 5.07 (+6.96%)
DGX.VN : 3.480 (-1.69%)
BCHT.TO : 4.98 (+365.42%)
GAME : 0.3850 (-3.75%)
ACNT : 16.19 (-2.18%)
WYY : 5.37 (-2.54%)
DCGO : 0.8778 (-0.28%)
DGXX : 2.55 (-1.54%)
SCNX : 0.5100 (+3.01%)
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update GlobeNewswire - Thu Nov 13, 2025

Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K Launched Sales of Arbli ™ , the First FDA-Approved Ready-To-Use Liquid Formulation of Losartan for...

SCNX : 0.5100 (+3.01%)
Scienture Holdings: Q3 Earnings Snapshot AP - Wed Nov 12, 2025

Scienture Holdings: Q3 Earnings Snapshot

SCNX : 0.5100 (+3.01%)
SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans GlobeNewswire - Tue Nov 4, 2025

Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and...

SCNX : 0.5100 (+3.01%)
SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium) GlobeNewswire - Thu Oct 23, 2025

Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli ™...

SCNX : 0.5100 (+3.01%)
SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers GlobeNewswire - Thu Oct 16, 2025

Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, creating...

SCNX : 0.5100 (+3.01%)

Barchart Exclusives

3 High-Yield Dividend Stocks Wall Street Still Trusts Barchart - 56 minutes ago
Reliable income stocks still wins when markets get unpredictable. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot